Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Three-year financial analysis of minimally invasive radio-guided parathyroidectomy.

Hutchinson JR, Yandell DW, Bumpous JM, Fleming MM, Flynn MB.

Am Surg. 2004 Dec;70(12):1112-5.

PMID:
15663056
2.

Deletions and point mutations of p16,p15 gene in primary tumors and tumor cell lines.

Yonghao T, Qian H, Chuanyuan L, Yandell DW.

Chin Med Sci J. 1999 Dec;14(4):200-5.

PMID:
12894891
3.

Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma.

Shattuck TM, Kim TS, Costa J, Yandell DW, Imanishi Y, Palanisamy N, Gaz RD, Shoback D, Clark OH, Monchik JM, Wierman ME, Hollenberg A, Tojo K, Chaganti RS, Arnold A.

Clin Endocrinol (Oxf). 2003 Aug;59(2):180-9.

PMID:
12864795
4.

[Mutations of several tumor suppressor genes in primary retinoblastoma].

Huang Q, Tao Y, Yandell DW.

Zhonghua Zhong Liu Za Zhi. 1999 Jan;21(1):10-2. Chinese.

PMID:
11776785
5.

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction.

Kupryjańczyk J, Dansonka-Mieszkowska A, Szymańska T, Karpińska G, Rembiszewska A, Rusin M, Konopiński R, Kraszewska E, Timorek A, Yandell DW, Stelmachów J.

Br J Cancer. 2000 Feb;82(3):579-83.

6.

[Distinct Rb gene point mutations in families showing low penetrance of hereditary retinoblastoma].

Huang Q, Dryja TP, Yandell DW.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998 Jun 10;15(3):139-42. Chinese.

PMID:
9621119
7.

[Gene diagnosis and genetic counselling of Rb gene mutations in retinoblastoma patients and their family members].

Huang Q, Dryja TP, Yandell DW.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998 Apr 10;15(2):65-8. Chinese.

PMID:
9531640
8.

The Familial Cancer Program of the Vermont Cancer Center: Development of a Cancer Genetics Program in a Rural Area.

McKinnon WC, Guttmacher AE, Greenblatt MS, Compas BE, May S, Cutler RE, Yandell DW.

J Genet Couns. 1997 Jun;6(2):131-45. doi: 10.1023/A:1025603900839.

PMID:
26142091
9.

Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma.

Kato MV, Shimizu T, Ishizaki K, Kaneko A, Yandell DW, Toguchida J, Sasaki MS.

Cancer Lett. 1996 Aug 23;106(1):75-82.

PMID:
8827049
10.

Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon.

Foulkes WD, Bolduc N, Lambert D, Ginsburg O, Olien L, Yandell DW, Tonin PN, Narod SA.

J Med Genet. 1996 Jul;33(7):534-9.

11.

Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease.

Kupryjanczyk J, Thor AD, Beauchamp R, Poremba C, Scully RE, Yandell DW.

Mod Pathol. 1996 Mar;9(3):166-73.

PMID:
8685209
12.

Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.

Rall CJ, Yan YX, Graeme-Cook F, Beauchamp R, Yandell DW, Povoski SP, Rustgi AK.

Pancreas. 1996 Jan;12(1):10-7.

PMID:
8927612
13.

Genetics of retinoblastoma: implications for other human cancers.

Yandell DW, Poremba C.

Med Pediatr Oncol Suppl. 1996;1:25-8. Review. No abstract available.

PMID:
8643044
14.

Detection of Heterozygous Mutation in the Retinoblastoma Gene in a Human Pituitary Adenoma Using PCR-SSCP Analysis and Direct Sequencing.

Ikeda H, Beauchamp RL, Yoshimoto T, Yandell DW.

Endocr Pathol. 1995 Autumn;6(3):189-196.

PMID:
12114739
15.

Adenocarcinoma of the cardia in a young man: detection of somatic p53 mutation by immunohistochemistry and automated direct sequencing.

Poremba C, Yandell DW, Mellin W, Schmid KW, Reers B, Böcker W, Dockhorn-Dworniczak B.

Pathol Res Pract. 1995 Oct;191(10):1004-9.

PMID:
8838368
16.

p53 gene analysis of ovarian borderline tumors and stage I carcinomas.

Kupryjanczyk J, Bell DA, Dimeo D, Beauchamp R, Thor AD, Yandell DW.

Hum Pathol. 1995 Apr;26(4):387-92.

PMID:
7705816
17.

Potential location of a bladder tumor suppressor gene on chromosome 9q at 9q13 to 9q22.1.

Lin CW, Zhang DS, Kwiatkowski DJ, Shipley WU, Scott McDougal W, Yandell DW.

Urol Oncol. 1995 Mar-Apr;1(2):88-92.

PMID:
21224098
18.

Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.

Poremba C, Yandell DW, Metze D, Kamanabrou D, Böcker W, Dockhorn-Dworniczak B.

Oncol Res. 1995;7(7-8):331-9.

PMID:
8747596
19.
20.

Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study.

Poremba C, Yandell DW, Huang Q, Little JB, Mellin W, Schmid KW, Böcker W, Dockhorn-Dworniczak B.

Virchows Arch. 1995;426(5):447-55.

PMID:
7633655
21.

The retinoblastoma gene is involved in malignant progression of astrocytomas.

Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN.

Ann Neurol. 1994 Nov;36(5):714-21.

PMID:
7979217
22.

p53 expression in ovarian borderline tumors and stage I carcinomas.

Kupryjańczyk J, Bell DA, Yandell DW, Scully RE, Thor AD.

Am J Clin Pathol. 1994 Nov;102(5):671-6.

PMID:
7942635
24.

Molecular characterization of the androgen receptor gene in boys with hypospadias.

Hiort O, Klauber G, Cendron M, Sinnecker GH, Keim L, Schwinger E, Wolfe HJ, Yandell DW.

Eur J Pediatr. 1994 May;153(5):317-21.

PMID:
8033918
25.

[Hypervariable regions (HVR) as genetic markers in tumor diagnosis. Methodological principles and their use in pathologic diagnosis].

Poremba C, Yandell DW, Spiro IJ, Heidl G, Böcker W, Dockhorn-Dworniczak B.

Pathologe. 1994 Apr;15(2):113-8. German.

PMID:
8197067
26.

Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms.

Dockhorn-Dworniczak B, Poremba C, Dantcheva R, Stücker A, Brömmelkamp E, Blasius S, Mellin W, Roessner A, Yandell DW, Böcker W.

Virchows Arch. 1994;424(4):337-42.

PMID:
7911380
27.

Complete genomic sequence of the human retinoblastoma susceptibility gene.

Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TP.

Genomics. 1993 Sep;17(3):535-43.

PMID:
7902321
28.

Accumulation of wild type p53 protein in human astrocytomas.

Rubio MP, von Deimling A, Yandell DW, Wiestler OD, Gusella JF, Louis DN.

Cancer Res. 1993 Aug 1;53(15):3465-7.

29.

Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver.

Spiro IJ, Yandell DW, Li C, Saini S, Ferry J, Powelson J, Katkov WN, Cosimi AB.

N Engl J Med. 1993 Jul 1;329(1):27-9. No abstract available.

30.
31.

p53 gene mutations and protein accumulation in human ovarian cancer.

Kupryjańczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW.

Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4961-5.

32.

Immature teratomas of different origin carried by a pregnant mother and her fetus.

Poremba C, Dockhorn-Dworniczak B, Merritt V, Li CY, Heidl G, Tauber PF, Böcker W, Yandell DW.

Diagn Mol Pathol. 1993 Jun;2(2):131-6.

PMID:
8269278
33.

p53 analysis in diagnostic pathology. Biologic implications and possible clinical applications.

Yandell DW, Thor AD.

Diagn Mol Pathol. 1993 Mar;2(1):1-3. No abstract available.

PMID:
8287220
34.

Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.

Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.

Cancer Res. 1993 Feb 15;53(4):846-50.

35.

Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism.

Thor AD, Yandell DW.

J Natl Cancer Inst. 1993 Feb 3;85(3):176-7. No abstract available.

PMID:
8423618
36.

Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K.

Cancer Res. 1993 Jan 15;53(2):368-72.

37.

How sensitive is PCR-SSCP?

Hayashi K, Yandell DW.

Hum Mutat. 1993;2(5):338-46. Review.

PMID:
8257985
38.

[Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer].

Castagnaro M, Yandell DW, Dockhorn-Dworniczak B, Wolfe HJ, Poremba C.

Verh Dtsch Ges Pathol. 1993;77:119-23. German.

PMID:
7511268
39.
40.

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Decker HJ, Wullich B, Whaley JM, Herrera G, Klauck SM, Sandberg AA, Yandell DW, Seizinger BR.

Cancer Genet Cytogenet. 1992 Oct 1;63(1):25-31.

PMID:
1423222
41.

Amplification and characterization of the retinoblastoma gene VNTR by PCR.

Scharf SJ, Bowcock AM, McClure G, Klitz W, Yandell DW, Erlich HA.

Am J Hum Genet. 1992 Feb;50(2):371-81.

42.

Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro.

Li CY, Yandell DW, Little JB.

Somat Cell Mol Genet. 1992 Jan;18(1):77-87.

PMID:
1546370
43.
44.

p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.

Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR.

Cancer Res. 1991 Dec 1;51(23 Pt 1):6393-6.

45.

SSCP (single strand conformation polymorphism) analysis of PCR fragments.

Yandell DW.

Jpn J Cancer Res. 1991 Dec;82(12):1468-9. No abstract available.

PMID:
1778778
46.

Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.

Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R.

Cancer Res. 1991 Oct 15;51(20):5736-43.

47.

A system for assaying homologous recombination at the endogenous human thymidine kinase gene.

Benjamin MB, Potter H, Yandell DW, Little JB.

Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6652-6.

48.

Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.

Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP.

Am J Hum Genet. 1991 May;48(5):880-8.

49.

Characterization of intragenic deletions in two sporadic germinal mutation cases of retinoblastoma resulting in abnormal gene expression.

Hashimoto T, Takahashi R, Yandell DW, Xu HJ, Hu SX, Gunnell S, Benedict WF.

Oncogene. 1991 Mar;6(3):463-9.

PMID:
2011402
50.

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes.

Rubin SJ, Hallahan DE, Ashman CR, Brachman DG, Beckett MA, Virudachalam S, Yandell DW, Weichselbaum RR.

J Surg Oncol. 1991 Jan;46(1):31-6.

PMID:
1986144

Supplemental Content

Loading ...
Support Center